GlassScriptPhysician profile
Alexander Avdashenko
NPI 1699964262
$1,791.70
in general payments reported to CMS, 2019-2025
10 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,118 · 2023: $73.88 · 2024: $257 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $981.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $269.20 | 2022-2024 | |
| Amgen INC. | $125.00 | 2025 | |
| Lilly USA, LLC | $120.97 | 2025 | Mounjaro, Zepbound |
| W. L. Gore & Associates, INC. | $100.47 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cordis US Corp. | $62.26 | 2022 | |
| Pfizer INC. | $40.31 | 2025 | |
| Philips North America LLC | $36.15 | 2025 | Mcot |
| Edwards Lifesciences Corporation | $34.94 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $20.86 | 2025 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Avdashenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.